paper-with-me

홈 › Papers

Machine learning predicts long-term mortality after acute myocardial infarction using systolic time intervals and routinely collected clinical data

2024-03-03 · Bijan Roudini, Boshra Khajehpiri, Hamid Abrishami Moghaddam, Mohamad Forouzanfar

Precise estimation of cardiac patients' current and future comorbidities is an important factor in prioritizing continuous physiological monitoring and new therapies. ML models have shown satisfactory performance in short-term mortality prediction of patients with heart disease, while their utility in long-term predictions is limited. This study aims to investigate the performance of tree-based ML models on long-term mortality prediction and the effect of two recently introduced biomarkers on long-term mortality. This study utilized publicly available data from CCHIA at the Ministry of Health and Welfare, Taiwan, China. Medical records were used to gather demographic and clinical data, including age, gender, BMI, percutaneous coronary intervention (PCI) status, and comorbidities such as hypertension, dyslipidemia, ST-segment elevation myocardial infarction (STEMI), and non-STEMI. Using medical and demographic records as well as two recently introduced biomarkers, brachial pre-ejection period (bPEP) and brachial ejection time (bET), collected from 139 patients with acute myocardial infarction, we investigated the performance of advanced ensemble tree-based ML algorithms (random forest, AdaBoost, and XGBoost) to predict all-cause mortality within 14 years. The developed ML models achieved significantly better performance compared to the baseline LR (C-Statistic, 0.80 for random forest, 0.79 for AdaBoost, and 0.78 for XGBoost, vs 0.77 for LR) (P-RF<0.001, PAdaBoost<0.001, PXGBoost<0.05). Adding bPEP and bET to our feature set significantly improved the algorithms' performance, leading to an absolute increase in C-Statistic of up to 0.03 (C-Statistic, 0.83 for random forest, 0.82 for AdaBoost, and 0.80 for XGBoost, vs 0.74 for LR) (P-RF<0.001, PAdaBoost<0.001, PXGBoost<0.05). This advancement may enable better treatment prioritization for high-risk individuals.

📄 PDF Abstract BibTeX arXiv:2403.01533

Code (0)

등록된 구현이 없습니다.

Tasks

Mortality Prediction

Methods 이 논문이 사용한 방법론

SET Dynamic Sparse Training method where weight mask is updated randomly periodically

Similar Papers 제목 키워드 기반

Random Forest-Based Prediction of Stroke Outcome

2024-02-01 · Carlos Fernandez-Lozano, Pablo Hervella, Virginia Mato-Abad, Manuel Rodriguez-Yanez 외

We research into the clinical, biochemical and neuroimaging factors associated with the outcome of stroke patients to generate a predictive model using machine learning techniques for prediction of mortality and morbidit…

Prediction

Deciphering infant mortality. Part 1: empirical evidence

2016-03-13

This paper is not (or at least not only) about human infant mortality. In line with reliability theory, "infant" will refer here to the time interval following birth during which the mortality (or failure) rate decreases…

Cardiac mortality prediction in patients undergoing PCI based on real and synthetic data

2025-12-24 · Daniil Burakov, Ivan Petrov, Dmitrii Khelimskii, Ivan Bessonov 외 arxiv

Patient status, angiographic and procedural characteristics encode crucial signals for predicting long-term outcomes after percutaneous coronary intervention (PCI). The aim of the study was to develop a predictive model …

Mortality PredictionFeature Importance

Quantifying Community Characteristics of Maternal Mortality Using Social Media

2020-04-14 · Rediet Abebe, Salvatore Giorgi, Anna Tedijanto, Anneke Buffone 외

While most mortality rates have decreased in the US, maternal mortality has increased and is among the highest of any OECD nation. Extensive public health research is ongoing to better understand the characteristics of c…

Direct Prediction of Cardiovascular Mortality from Low-dose Chest CT using Deep Learning

2018-10-04 · Sanne G. M. van Velzen, Majd Zreik, Nikolas Lessmann, Max A. Viergever 외

Cardiovascular disease (CVD) is a leading cause of death in the lung cancer screening population. Chest CT scans made in lung cancer screening are suitable for identification of participants at risk of CVD. Existing meth…